The Fate Of Calf Perforators After Endovenous Laser Ablation Of Saphenous Veins

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Ugur Ozkan, MD, Baskent University

ClinicalTrials.gov Identifier:

NCT01458795

First received: October 20, 2011

Last updated: November 2, 2011

Last verified: November 2011

History of Changes

Tracking Information
First Received Date ^ICMJE	October 20, 2011
Last Updated Date	November 2, 2011
Start Date ^ICMJE
Primary Completion Date
Current Primary Outcome Measures ^ICMJE
Original Primary Outcome Measures ^ICMJE
Change History	Complete list of historical versions of study NCT01458795 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures ^ICMJE
Original Secondary Outcome Measures ^ICMJE
Current Other Outcome Measures ^ICMJE
Original Other Outcome Measures ^ICMJE

Descriptive Information
Brief Title ^ICMJE	The Fate Of Calf Perforators After Endovenous Laser Ablation Of Saphenous Veins
Official Title ^ICMJE	The Fate Of Calf Perforators After Endovenous Laser Ablation Of Saphenous Veins
Brief Summary	The aim of this study is to evaluate the morphologic and hemodynamic changes in the calf perforators after endovenous laser ablation of saphenous veins.
Detailed Description
Study Type ^ICMJE	Interventional
Study Phase	Phase 4
Study Design ^ICMJE	Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Primary Purpose: Treatment
Condition ^ICMJE	Venous Insufficiency
Intervention ^ICMJE	Procedure: Endovenous laser ablation
Study Arm (s)
Publications *
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information
Recruitment Status ^ICMJE	Completed
Estimated Enrollment ^ICMJE	60
Completion Date
Primary Completion Date
Eligibility Criteria ^ICMJE	Inclusion Criteria: Symptomatic patients who undergo EVLA procedure for saphenous vein insufficiency Exclusion Criteria: Patients with a history of deep venous thrombosis (DVT) Previous varicose vein surgery or injection sclerotherapy Patients without superficial venous incompetency
Gender	Both
Ages	20 Years to 80 Years
Accepts Healthy Volunteers
Contacts ^ICMJE	Contact information is only displayed when the study is recruiting subjects
Location Countries ^ICMJE	Turkey

Administrative Information
NCT Number ^ICMJE	NCT01458795
Other Study ID Numbers ^ICMJE	bask 012
Has Data Monitoring Committee	Yes
Responsible Party	Ugur Ozkan, MD, Baskent University
Study Sponsor ^ICMJE	Baskent University
Collaborators ^ICMJE
Investigators ^ICMJE
Information Provided By	Baskent University
Verification Date	November 2011
^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top